Rivaroxaban, an inhibitor of factor Xa, has demonstrated superior efficacy to enoxaparin, a low-molecular-weight heparin, in the prevention of venous thrombosis after joint replacement. The results ...
Zacks.com on MSN
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
CRMD's lead product, DefenCath, generates $167.6M in sales in the first nine months of 2025, with market exclusivity through 2033 likely to provide growth momentum.
Ranked by Local offices Pro Bono hours donated in 2024 Ranked by Taxes levied in 2024 Showcase your company news with guaranteed exposure both in print and online Join Charlotte Business Journal for ...
ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...
Together For Palestine's Lullaby enters Christmas Number 1 race ...
Prime Contractor: Boeing (airframe) and CFM International (engines) Services: USAF, USN Power Plant: Two GE CFM 56-7B27 turbofan engines Speed: 530 mph (Mach 0.8) Ceiling: 41,000 feet (12,727 meters) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback